Cell Sources Proposed for Nucleus Pulposus Regeneration

Overview

Journal JOR Spine

Specialty Orthopedics

Date 2022 Jan 10

PMID 35005441

Authors

Rebecca J Williams

Marianna A Tryfonidou

Joseph Wiliam Snuggs

Christine Lyn Le Maitre

Affiliations

Soon will be listed here.

Abstract

Lower back pain (LBP) occurs in 80% of adults in their lifetime; resulting in LBP being one of the biggest causes of disability worldwide. Chronic LBP has been linked to the degeneration of the intervertebral disc (IVD). The current treatments for chronic back pain only provide alleviation of symptoms through pain relief, tissue removal, or spinal fusion; none of which target regenerating the degenerate IVD. As nucleus pulposus (NP) degeneration is thought to represent a key initiation site of IVD degeneration, cell therapy that specifically targets the restoration of the NP has been reviewed here. A literature search to quantitatively assess all cell types used in NP regeneration was undertaken. With key cell sources: NP cells; annulus fibrosus cells; notochordal cells; chondrocytes; bone marrow mesenchymal stromal cells; adipose-derived stromal cells; and induced pluripotent stem cells extensively analyzed for their regenerative potential of the NP. This review highlights: accessibility; expansion capability in vitro; cell survival in an IVD environment; regenerative potential; and safety for these key potential cell sources. In conclusion, while several potential cell sources have been proposed, iPSC may provide the most promising regenerative potential.

Citing Articles

Explorative Study of Modulatory Effects of Notochordal Cell-Derived Extracellular Vesicles on the IL-1β-Induced Catabolic Cascade in Nucleus Pulposus Cell Pellets and Explants.

van Maanen J, Bach F, Snuggs J, Ito K, Wauben M, Le Maitre C JOR Spine. 2025; 8(1):e70043.

PMID: 39881783 PMC: 11775941. DOI: 10.1002/jsp2.70043.

Alginate vs. Hyaluronic Acid as Carriers for Nucleus Pulposus Cells: A Study on Regenerative Outcomes in Disc Degeneration.

Ogasawara S, Schol J, Sakai D, Warita T, Susumu T, Nakamura Y Cells. 2024; 13(23).

PMID: 39682732 PMC: 11639827. DOI: 10.3390/cells13231984.

From structure to therapy: the critical influence of cartilaginous endplates and microvascular network on intervertebral disc degeneration.

Sun Y, Li Z, Duan J, Liu E, Yang L, Sun F Front Bioeng Biotechnol. 2024; 12:1489420.

PMID: 39530056 PMC: 11550963. DOI: 10.3389/fbioe.2024.1489420.

A novel spine tester TO GO.

Jansen J, Zengerle L, Steiner M, Sciortino V, Tryfonidou M, Wilke H JOR Spine. 2024; 7(4):e70002.

PMID: 39469185 PMC: 11513258. DOI: 10.1002/jsp2.70002.

Allogenic bone marrow-derived mesenchymal stromal cell-based therapy for patients with chronic low back pain: a prospective, multicentre, randomised placebo controlled trial (RESPINE study).

Pers Y, Soler-Rich R, Vadala G, Ferreira R, Duflos C, Picot M Ann Rheum Dis. 2024; 83(11):1572-1583.

PMID: 39393844 PMC: 11503111. DOI: 10.1136/ard-2024-225771.

References

Henriksson H, Svanvik T, Jonsson M, Hagman M, Horn M, Lindahl A . Transplantation of human mesenchymal stems cells into intervertebral discs in a xenogeneic porcine model. Spine (Phila Pa 1976). 2008; 34(2):141-8. DOI: 10.1097/BRS.0b013e31818f8c20. View

Risbud M, Guttapalli A, Tsai T, Lee J, Danielson K, Vaccaro A . Evidence for skeletal progenitor cells in the degenerate human intervertebral disc. Spine (Phila Pa 1976). 2007; 32(23):2537-44. DOI: 10.1097/BRS.0b013e318158dea6. View

Urban J, Holm S, Maroudas A . Diffusion of small solutes into the intervertebral disc: as in vivo study. Biorheology. 1978; 15(3-4):203-21. DOI: 10.3233/bir-1978-153-409. View

Hua J, Shen N, Wang J, Tao Y, Li F, Chen Q . Small Molecule-Based Strategy Promotes Nucleus Pulposus Specific Differentiation of Adipose-Derived Mesenchymal Stem Cells. Mol Cells. 2019; 42(9):661-671. PMC: 6776160. DOI: 10.14348/molcells.2019.0098. View

Bhunia B, Kaplan D, Mandal B . Silk-based multilayered angle-ply annulus fibrosus construct to recapitulate form and function of the intervertebral disc. Proc Natl Acad Sci U S A. 2017; 115(3):477-482. PMC: 5776988. DOI: 10.1073/pnas.1715912115. View

Tong W, Lu Z, Qin L, Mauck R, Smith H, Smith L . Cell therapy for the degenerating intervertebral disc. Transl Res. 2016; 181:49-58. PMC: 5776755. DOI: 10.1016/j.trsl.2016.11.008. View

Vadala G, Sobajima S, Lee J, Huard J, Denaro V, Kang J . In vitro interaction between muscle-derived stem cells and nucleus pulposus cells. Spine J. 2007; 8(5):804-9. DOI: 10.1016/j.spinee.2007.07.394. View

Kuh S, Zhu Y, Li J, Tsai K, Fei Q, Hutton W . A comparison of three cell types as potential candidates for intervertebral disc therapy: annulus fibrosus cells, chondrocytes, and bone marrow derived cells. Joint Bone Spine. 2008; 76(1):70-4. DOI: 10.1016/j.jbspin.2008.02.021. View

Arkesteijn I, Potier E, Ito K . The Regenerative Potential of Notochordal Cells in a Nucleus Pulposus Explant. Global Spine J. 2017; 7(1):14-20. PMC: 5400162. DOI: 10.1055/s-0036-1583174. View

10.

Binch A, Cole A, Breakwell L, Michael A, Chiverton N, Cross A . Expression and regulation of neurotrophic and angiogenic factors during human intervertebral disc degeneration. Arthritis Res Ther. 2014; 16(5):416. PMC: 4177417. DOI: 10.1186/s13075-014-0416-1. View

11.

Perez-Cruet M, Beeravolu N, McKee C, Brougham J, Khan I, Bakshi S . Potential of Human Nucleus Pulposus-Like Cells Derived From Umbilical Cord to Treat Degenerative Disc Disease. Neurosurgery. 2018; 84(1):272-283. PMC: 6292795. DOI: 10.1093/neuros/nyy012. View

12.

Luoma K, Riihimaki H, Luukkonen R, Raininko R, Viikari-Juntura E, Lamminen A . Low back pain in relation to lumbar disc degeneration. Spine (Phila Pa 1976). 2000; 25(4):487-92. DOI: 10.1097/00007632-200002150-00016. View

13.

Tsaryk R, Silva-Correia J, Oliveira J, Unger R, Landes C, Brochhausen C . Biological performance of cell-encapsulated methacrylated gellan gum-based hydrogels for nucleus pulposus regeneration. J Tissue Eng Regen Med. 2014; 11(3):637-648. DOI: 10.1002/term.1959. View

14.

Borem R, Madeline A, Bowman M, Gill S, Tokish J, Mercuri J . Differential Effector Response of Amnion- and Adipose-Derived Mesenchymal Stem Cells to Inflammation; Implications for Intradiscal Therapy. J Orthop Res. 2019; 37(11):2445-2456. DOI: 10.1002/jor.24412. View

15.

Zhao Y, Qin Y, Yang J, Huang D, Hu H, Wang X . Wharton's Jelly-derived mesenchymal stem cells suppress apoptosis of nucleus pulposus cells in intervertebral disc degeneration via Wnt pathway. Eur Rev Med Pharmacol Sci. 2020; 24(19):9807-9814. DOI: 10.26355/eurrev_202010_23190. View

16.

Lin X, Fang X, Wang Q, Hu Z, Chen K, Shan Z . Decellularized allogeneic intervertebral disc: natural biomaterials for regenerating disc degeneration. Oncotarget. 2016; 7(11):12121-36. PMC: 4914273. DOI: 10.18632/oncotarget.7735. View

17.

Wang X, Meng Q, Qiu C, Li P, Qu R, Wang W . Potential therapeutic role of Co-Q10 in alleviating intervertebral disc degeneration and suppressing IL-1β-mediated inflammatory reaction in NP cells. Int Immunopharmacol. 2018; 64:424-431. DOI: 10.1016/j.intimp.2018.09.029. View

18.

Jeong J, Lee J, Jin E, Min J, Jeon S, Choi K . Regeneration of intervertebral discs in a rat disc degeneration model by implanted adipose-tissue-derived stromal cells. Acta Neurochir (Wien). 2010; 152(10):1771-7. DOI: 10.1007/s00701-010-0698-2. View

19.

Bach F, Tellegen A, Beukers M, Miranda-Bedate A, Teunissen M, de Jong W . Biologic canine and human intervertebral disc repair by notochordal cell-derived matrix: from bench towards bedside. Oncotarget. 2018; 9(41):26507-26526. PMC: 5995168. DOI: 10.18632/oncotarget.25476. View

20.

Chon B, Lee E, Jing L, Setton L, Chen J . Human umbilical cord mesenchymal stromal cells exhibit immature nucleus pulposus cell phenotype in a laminin-rich pseudo-three-dimensional culture system. Stem Cell Res Ther. 2014; 4(5):120. PMC: 3854685. DOI: 10.1186/scrt331. View